SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Ministry of Health Approves BrainStorm Cell Therapeutics Inc.’s NurOwn™ for the First Clinical Trial of Adult Stem Cell Therapy for ALS